Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Peter E. Lipsky's publication output changed over time?
ScholarIQpublication output · 1998–2018
Output grew0% over the shown period — from 1 works in 1998 to 1 in 2018.
1
2
1
2
1
1
1
1
1
1
1998199920002001200220042005200620072018
What are the most-cited papers on Peter E. Lipsky?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
New England Journal of Medicine. 20003,023 CitationsOPEN ACCESS
Cyclooxygenase in biology and disease
Raymond N. DuBois, Steven B. Abramson, Leslie J. Crofford, Rajnish A. Gupta, Lee S. Simon, L. B. A. van de Putte, Peter E. Lipsky
The FASEB Journal. 19982,508 Citations
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
The Lancet. 19992,360 Citations
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Sheng Chen, Sheng Chen, Gary P. Sims, Xiao Xiang Chen, Yue Ying Gu, Shunle Chen, Shun‐le Chen, Peter E. Lipsky
S38008053. 20071,123 CitationsOPEN ACCESS
Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
Lee S. Simon, Arthur L. Weaver, David Y. Graham, Alan Kivitz, Peter E. Lipsky, Richard C. Hubbard, Peter C. Isakson, Kenneth M. Verburg, Shawn Yu, William W. Zhao, Gilbert Geis
JAMA. 1999804 Citations
Related on ScholarIQ
Ampel BioSolutions (United States)
Institution
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Paper
Cyclooxygenase in biology and disease
Paper
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Paper
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Paper
Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
Paper